May 11, 2022 / 03:40PM GMT
Kevin Mark Fischbeck - BofA Securities, Research Division - MD in Equity Research
(technical difficulty) tech-enabled managed care company focused on the Medicare Advantage business. Presenting today, we have John Kao, the CEO; and Thomas Freeman, the CFO of the company. And I think we should jump right into Q&A.
Questions and Answers:
Kevin Mark Fischbeck - BofA Securities, Research Division - MD in Equity ResearchSo I guess any updated thoughts on utilization. Obviously, COVID peaks and values and core utilization, it seemed like generally, things were under control heading into Q1. But I guess what are you seeing and what are you assuming as far as future spikes of COVID?
Robert Thomas Freeman - Alignment Healthcare, Inc. - CFO
Yes. Maybe I can take that one. So we feel probably similar to what you've heard from others and that Q1 was interesting. We obviously had a great quarter, very proud of our performance. But if you had asked us in October coming off the Delta wave, whether we thought another
Trustpilot
